Neurotrophic Keratopathy Stage 1 Clinical Trials in Tampa, Florida

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency